ClinicalTrials.Veeva

Menu

Elastography vs Iron Regulators in the Diagnosis of Hepatic Fibrosis- Iron Overload in Children With Beta- Thalassemia

T

Tanta University

Status

Completed

Conditions

Beta Thalassemia Major
Liver Fibrosis

Treatments

Diagnostic Test: Serum ferritin
Diagnostic Test: Serum hepcidin

Study type

Observational

Funder types

Other

Identifiers

NCT07153926
36264PR872/9/24

Details and patient eligibility

About

The goal of this cross-sectional observational study is to evaluate the accuracy of serum ferritin and serum hepcidin versus non-invasive scores in the diagnosis of liver fibrosis and iron overload in beta- thalassemia children.

Researchers will measure and correlate serum ferritin, hepcidin and hepcidin/ferritin ratio in beta- thalassemia children with liver fibrosis. Researchers will also evaluate the performance of serum ferritin, hepcidin and hepcidin/ferritin ratio, AST to platelet ratio index (APRI) score, and fibrosis-4 (FIB-4) score, for predicting significant fibrosis (>=F2).

Participants will undergo history-taking, clinical examination, laboratory investigations, serum ferritin, serum hepcidin, abdominal ultrasonography, and Fibroscan examination. The APRI, FIB-4, and hepcidin/ferritin ratio will be calculated. The performance of serum ferritin, hepcidin and hepcidin/ferritin ratio for predicting significant fibrosis will be compared versus other non-invasive scores.

Enrollment

100 patients

Sex

All

Ages

5 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Children with ß-thalassemia major
  • iron overload, as indicated by serum ferritin levels more than 500 ng/mL.

Exclusion criteria

  • Pediatric patients with liver diseases (such as hepatitis).
  • children with other types of chronic hemolytic anemia.
  • other chronic systemic diseases (DM and Hypertension) or malignancy or heart diseases.

Trial design

100 participants in 1 patient group

beta- thalassemia patients
Description:
100 beta-thalassemia major children with iron overload aged 5 to 18 years, as indicated by serum ferritin levels more than 500 ng/mL.
Treatment:
Diagnostic Test: Serum hepcidin
Diagnostic Test: Serum ferritin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems